EP Patent

EP1632259A2 — Anti-angiogene compositions and methods of use

Assigned to University of British Columbia · Expires 2006-03-08 · 20y expired

What this patent protects

The present invention provides compositions an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives therof, and taxol. Also provided are methods for embolizing blood vessel…

USPTO Abstract

The present invention provides compositions an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives therof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.

Drugs covered by this patent

Patent Metadata

Patent number
EP1632259A2
Jurisdiction
EP
Classification
—
Expires
2006-03-08
Drug substance claim
No
Drug product claim
No
Assignee
University of British Columbia
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.